Breaking News Bar

Business News and Information

Sarepta Therapeutics (NQ: SRPT )

96.82 USD +0.06 (+0.06%)

Streaming Delayed Price Updated: 1:39 PM EST, Jan 21, 2021 Add to My Watchlist

Price and Volume

Volume	1,005,981
Open	99.03
Bid (Size)	96.75 (1)
Ask (Size)	96.89 (4)
Prev. Close	96.76
Today's Range	94.28 - 99.03
52wk Range	78.06 - 181.83
Shares Outstanding	65,531,046
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Sarepta Therapeutics and Genevant Sciences Announce Research Collaboration for Lipid Nanoparticle-Based Gene Editing Therapeutics

January 13, 2021

Sarepta Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm

January 12, 2021

Performance

YTD	-41.42%	-41.42%
1 Month	-45.31%	-45.31%
3 Month	-29.46%	-29.46%
6 Month	-41.15%	-41.15%
1 Year	-21.28%	-21.28%

More News

SHAREHOLDER ALERT: Barr Law Group Investigating the Officers and Directors of SRPT, PS, RP, and PGZ; Shareholders are Encouraged to Contact the Firm

January 12, 2021

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

January 12, 2021

SRPT EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Sarepta Therapeutics, Inc.; Encourages Investors with Losses Exceeding $1 Million to Contact Fir

January 09, 2021

Noteworthy Wednesday Option Activity: CALX, CCS, SRPT

January 20, 2021

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

January 08, 2021

NASDAQ:SRPT Shareholder Notice: Investigation over Potential Securities Laws Violations by Sarepta Therapeutics, Inc.

January 18, 2021

SRPT EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Sarepta Therapeutics, Inc. – SRPT

January 08, 2021

The Week Ahead In Biotech (Jan 10-16): Expect Stocks To Move As J.P. Morgan Healthcare Conference Kicks Off

January 09, 2021

Here's Why Sarepta Therapeutics Lost Support on Wall Street

January 10, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

bottom clear

About Us